tiprankstipranks
Advertisement
Advertisement

ASMB Stock Latest News

Assembly Biosciences price target raised to $45 from $40 at Mizuho
The FlyAssembly Biosciences price target raised to $45 from $40 at Mizuho
9d ago
ASMB
Assembly Biosciences Expands Equity Plans, Reelects Board
PremiumCompany Announcements
Assembly Biosciences Expands Equity Plans, Reelects Board
19d ago
8K
ASMB
Assembly Biosciences Completes Significant Equity Offering Financing
PremiumCompany Announcements
Assembly Biosciences Completes Significant Equity Offering Financing
29d ago
8K
ASMB
Assembly Biosciences Expands ABI-6250 Liver Disease Program
PremiumCompany Announcements
Assembly Biosciences Expands ABI-6250 Liver Disease Program
1M ago
8K
ASMB
Assembly Biosciences announces expansion of ABI-6250 clinical development
PremiumThe Fly
Assembly Biosciences announces expansion of ABI-6250 clinical development
1M ago
ASMB
Analyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway
PremiumRatingsAnalyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway
1M ago
ASMB
Assembly Biosciences reports Q1 EPS (54c), consensus (64c)
Premium
The Fly
Assembly Biosciences reports Q1 EPS (54c), consensus (64c)
2M ago
ASMB
ASMB Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ASMB Earnings this Week: How Will it Perform?
2M ago
ASMB
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
PremiumThe Fly
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
3M ago
ASMB
GILD
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
PremiumCompany Announcements
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
3M ago
8K
ASMB
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
PremiumCompany Announcements
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
3M ago
ASMB
Assembly Biosciences files $400M mixed securities shelf
PremiumThe Fly
Assembly Biosciences files $400M mixed securities shelf
3M ago
ASMB
Is ASMB a Buy, Before Earnings?
PremiumPre-EarningsIs ASMB a Buy, Before Earnings?
4M ago
ASMB
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
Premium
Ratings
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
6M ago
ASMB
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
Premium
The Fly
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
6M ago
ASMB
GILD
Gilead exercises option to license Assembly helicase-primase inhibitor programs
PremiumThe Fly
Gilead exercises option to license Assembly helicase-primase inhibitor programs
6M ago
ASMB
GILD
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
PremiumCompany Announcements
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
6M ago
ASMB
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
PremiumRatings
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
7M ago
ASMB
Assembly Biosciences Reports Positive Phase 1b Results
PremiumCompany Announcements
Assembly Biosciences Reports Positive Phase 1b Results
7M ago
8K
ASMB
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
PremiumThe FlyAssembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
7M ago
ASMB
GILD
Assembly Biosciences price target raised to $40 from $29 at Mizuho
Premium
The Fly
Assembly Biosciences price target raised to $40 from $29 at Mizuho
7M ago
ASMB
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
Premium
Ratings
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
7M ago
ASMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >